The impact of plaque type on strut embedment/protrusion and shear stress distribution in bioresorbable scaffold.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 22 11 2018
revised: 17 04 2019
accepted: 22 05 2019
pubmed: 20 6 2019
medline: 29 6 2021
entrez: 20 6 2019
Statut: ppublish

Résumé

Scaffold design and plaque characteristics influence implantation outcomes and local flow dynamics in treated coronary segments. Our aim is to assess the impact of strut embedment/protrusion of bioresorbable scaffold on local shear stress distribution in different atherosclerotic plaque types. Fifteen Absorb everolimus-eluting Bioresorbable Vascular Scaffolds were implanted in human epicardial coronary arteries. Optical coherence tomography (OCT) was performed post-scaffold implantation and strut embedment/protrusion were analysed using a dedicated software. OCT data were fused with angiography to reconstruct 3D coronary anatomy. Blood flow simulation was performed and wall shear stress (WSS) was estimated in each scaffolded surface and the relationship between strut embedment/protrusion and WSS was evaluated. There were 9083 struts analysed. Ninety-seven percent of the struts (n = 8840) were well-apposed and 243 (3%) were malapposed. At cross-section level (n = 1289), strut embedment was significantly increased in fibroatheromatous plaques (76 ± 48 µm) and decreased in fibrocalcific plaques (35 ± 52 µm). Compatible with strut embedment, WSS was significantly higher in lipid-rich fibroatheromatous plaques (1.50 ± 0.81 Pa), whereas significantly decreased in fibrocalcified plaques (1.05 ± 0.91 Pa). After categorization of WSS as low (<1.0 Pa) and normal/high WSS (≥1.0 Pa), the percent of low WSS in the plaque subgroups were 30.1%, 31.1%, 25.4%, and 36.2% for non-diseased vessel wall, fibrous plaque, fibroatheromatous plaque, and fibrocalcific plaque, respectively (P-overall < 0.001). The composition of the underlying plaque influences strut embedment which seems to have effect on WSS. The struts deeply embedded in lipid-rich fibroatheromas plaques resulted in higher WSS compared with the other plaque types.

Identifiants

pubmed: 31215995
pii: 5520594
doi: 10.1093/ehjci/jez155
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

454-462

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Ryo Torii (R)

Department of Mechanical Engineering, University College London, London, UK.

Erhan Tenekecioglu (E)

Department of Interventional Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.

Yuki Katagiri (Y)

Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Ply Chichareon (P)

Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Yohei Sotomi (Y)

Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Jouke Dijkstra (J)

LKEB-Division of Image Processing, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Taku Asano (T)

Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Rodrigo Modolo (R)

Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Kuniaki Takahashi (K)

Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Hans Jonker (H)

Cardialysis, Rotterdam, The Netherlands.

Robert van Geuns (R)

Department of Interventional Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.

Yoshinobu Onuma (Y)

Department of Interventional Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.

Kerem Pekkan (K)

Department of Mechanical Engineering, Koc University, Istanbul, Turkey.

Christos V Bourantas (CV)

Institute of Cardiovascular Science, University College London, London, UK.
Department of Cardiology, Barts Heart Centre, London, UK.

Patrick W Serruys (PW)

Department of Interventional Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.
Imperial College, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH